According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.16. In 2025 the company made an earnings per share (EPS) of -ยฃ0.05977 a decrease over its 2024 EPS that were of ยฃ0.02989.